Stock listing

KRX:389650 Nextbiomedical Co. Ltd. (넥스트바이오메디컬) 주가

Follow Nextbiomedical Co. Ltd. into a list and get an email when it puts out news.

Share price · KRX:389650

₩23,800 KRW -100 (-0.4%)

Close on Nov 20, 2026

Past year -65.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩23,800 – ₩24,700 KRWNov 20, 2026
Volume
12,162 sharesNov 20, 2026
Market cap
₩197.0B KRWAt the close on Nov 20, 2026 · price × 8.28M shares outstanding
52-week range
₩22,900 – ₩101,000 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩741.9M KRWMedian day 22,169 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Nextbiomedical Co. Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:389650 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩23,800-100-0.4%₩24,700₩24,700₩23,80012,162
₩23,900+450+1.9%₩23,600₩24,600₩23,2509,755
₩23,450-350-1.5%₩23,200₩24,250₩22,90027,318
₩23,800-2,500-9.5%₩26,350₩26,750₩23,80030,776
₩26,300-1,350-4.9%₩27,650₩28,900₩26,15022,183
₩27,650-1,350-4.7%₩28,550₩29,500₩27,40018,913
₩29,000+650+2.3%₩28,300₩29,950₩28,30018,973
₩28,350+1,850+7.0%₩27,200₩28,350₩26,85015,675
₩26,500-1,050-3.8%₩27,500₩28,000₩26,35022,822
₩27,550-1,000-3.5%₩26,900₩28,450₩26,25022,011
₩28,550-750-2.6%₩29,600₩30,400₩28,00017,639
₩29,300-150-0.5%₩29,500₩30,600₩27,70032,549
₩29,450+800+2.8%₩28,300₩30,250₩28,00036,631
₩28,650+1,500+5.5%₩27,000₩28,800₩27,00017,747
₩27,150-1,200-4.2%₩28,500₩28,650₩26,90031,469
₩28,350-950-3.2%₩28,850₩29,050₩28,35015,176
₩29,300+1,300+4.6%₩28,550₩29,500₩27,95035,665
₩28,000+850+3.1%₩27,750₩29,300₩27,50024,337
₩27,150-50-0.2%₩26,900₩28,000₩26,50012,396
₩27,200+750+2.8%₩25,600₩27,200₩25,20023,247
₩26,450-1,250-4.5%₩27,750₩28,000₩26,20019,026
₩27,700+700+2.6%₩27,200₩29,050₩27,00025,380
₩27,000-800-2.9%₩27,100₩28,350₩26,40042,122
₩27,800+1,450+5.5%₩25,550₩27,800₩25,55014,362
₩26,350+800+3.1%₩25,400₩27,200₩25,40019,552
₩25,550-1,350-5.0%₩25,450₩26,400₩25,15027,456
₩26,900-400-1.5%₩27,100₩27,750₩26,80029,309
₩27,300-900-3.2%₩27,900₩28,000₩26,45029,745
₩28,200-1,500-5.1%₩29,500₩29,650₩28,15030,197
₩29,700-1,800-5.7%₩31,000₩31,000₩28,25058,218
₩31,50000.0%₩31,600₩32,050₩31,2007,526
₩31,500-250-0.8%₩31,750₩32,600₩31,10017,419
₩31,750-1,450-4.4%₩33,100₩33,400₩31,60021,520
₩33,200+750+2.3%₩32,600₩33,850₩31,40049,129
₩32,450+1,800+5.9%₩30,750₩32,950₩30,60037,254
₩30,650-700-2.2%₩31,800₩31,800₩30,30013,918
₩31,350-1,050-3.2%₩32,700₩33,050₩31,35025,308
₩32,400+4,100+14.5%₩28,450₩33,450₩28,15075,810
₩28,300-350-1.2%₩28,550₩29,400₩28,30025,180
₩28,65000.0%₩28,800₩30,200₩28,40019,196
₩28,650-1,000-3.4%₩29,600₩30,000₩28,65017,874
₩29,650+450+1.5%₩29,000₩30,100₩29,00016,528
₩29,200-950-3.2%₩30,050₩30,050₩28,70013,473
₩30,150+750+2.6%₩30,000₩32,150₩29,95074,337
₩29,400-100-0.3%₩28,700₩30,150₩28,65015,810
₩29,500-50-0.2%₩29,250₩29,750₩28,55018,033
₩29,550-850-2.8%₩30,400₩30,450₩29,55018,979
₩30,400-50-0.2%₩30,450₩30,950₩30,2009,258
₩30,450-600-1.9%₩30,850₩31,800₩30,05022,154
₩31,05000.0%₩31,050₩31,250₩30,50012,201
₩31,050-50-0.2%₩31,100₩31,800₩30,60029,493
₩31,100-900-2.8%₩32,300₩32,800₩31,00018,502
₩32,000-1,350-4.0%₩32,800₩34,300₩31,95025,897
₩33,350+150+0.5%₩32,900₩34,500₩32,20022,692
₩33,200+200+0.6%₩32,400₩33,225₩31,10024,864
₩33,000-450-1.3%₩33,050₩33,450₩31,95018,750
₩33,450-100-0.3%₩33,100₩33,800₩32,65022,823
₩33,550+600+1.8%₩32,750₩33,700₩32,00017,727
₩32,950-300-0.9%₩33,000₩33,100₩31,05016,751
₩33,250+950+2.9%₩33,300₩33,300₩31,80023,571
₩32,300-2,200-6.4%₩34,000₩34,000₩31,15046,251
₩34,500+1,400+4.2%₩34,350₩34,850₩33,00033,096
Ticker
KRX:389650
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
KRX
Currency
KRW

What changed lately

Latest news

All Nextbiomedical Co. Ltd. news

Nextbiomedical Co. Ltd. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
1 in the last 12 months · 3 in all · newest Jul 6, 2026 · oldest 2025

Valuation

P/E 847× against a median of 30.6×: the highest of 6 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩162.6B KRW
P/E
847×
EV/sales
9.1×
EV/EBITDA
Negative EBITDA
Price/book
4.0×
Gross margin
70.5%
Operating margin
−12.9%
Net margin
1.3%
Debt to equity
0.0×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Nextbiomedical Co. Ltd. · KRX:389650US$146.4MUS$120.9M847×9.1×n/a4.0×1.3%0.0×n/a
Pacific Hospital Supply Co., Ltd. · TPEX:4126US$158.8MUS$116.7M12.1×1.6×6.3×1.8×17.9%0.0×n/a
PW Medtech Group Ltd. · HKEX:1358US$156.6M−US$114.6M11.1×−0.9×−2.9×0.3×11.5%0.0×n/a
CUREXO Inc. · KRX:060280US$152.5MUS$133.1M37.2×2.3×29.7×2.0×7.1%0.0×n/a
Delta Asia International Corporation · TPEX:6762US$151.3MUS$152.0M213×7.2×18.2×3.8×3.4%0.2×n/a
KORU Medical Systems, Inc. · NASDAQ:KRMDUS$147.3MUS$3.17Tn/a68,440×15,926,569×7.6×−1.8%163,275×1.06
Paxman AB · OMXSTO:PAXUS$146.5MUS$137.3Mn/a3.8×36.9×3.6×−1.4%0.0×n/a
TriSalus Life Sciences, Inc. · NASDAQ:TLSIUS$143.1MUS$134.5Mn/a2.9×n/a211×−56.6%47.6×1.22
Inogen, Inc · NASDAQ:INGNUS$140.7MUS$58.75Mn/a0.2×n/a0.9×−10.1%0.1×0.64
Asterasys Co., Ltd. · KRX:450950US$138.3MUS$124.7M30.6×4.2×26.8×4.1×15.4%0.0×n/a
Hans Biomed Corp · KRX:042520US$135.1MUS$125.0Mn/a1.4×n/a2.3×−15.8%0.1×n/a
Median of the othersUS$146.9MUS$129.1M30.6×2.6×26.8×3.0×1.0%0.1×1.06

Forecasts

Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.

Price target
77500.00 KRW · Analysts' mean
EPS, year to Dec 2026
-351.00 · 2 analysts
Revenue, year to Dec 2026
22.33B · 3 analysts

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue16.5B9.54B4.88B2.80B2.27B
Cost of revenue4.95B3.72B2.77B2.51B2.89B
Gross profit11.5B5.82B2.11B284.5M-624.8M
Research and development7.58B6.62B4.78B3.58B3.25B
Selling, general and administrative1.60B2.70B2.47B2.37B1.29B
Operating income-719.5M1.52B-7.65B-4.86B-6.97B
Depreciation and amortization518.5M391.9M381.9M379.1M433.5M
EBITDA-201.0M1.91B-7.27B-4.48B-6.54B
Interest expense367.3M520.1M574.4M360.4M1.41B
Income before tax-311.1M2.86B-7.52B-5.73B-16.6B
Net income-311.1M2.86B-7.52B-5.73B-16.6B
Earnings per share, basic-38.28353.61-939.24-715.76-2,078.52

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents6.79B308.0K262.0K491.0K22.0B
Short-term investments30.2B36.7B10.4B11.8B
Receivables2.24B1.85B1.03B389.1M118.7M
Inventory3.04B2.58B2.17B1.94B1.31B
Current assets43.3B46.9B18.0B17.5B23.7B
Property, plant and equipment11.3B11.4B11.7B
Total assets59.3B58.8B29.6B32.1B39.7B
Accounts payable47.7M13.4M58.2M45.0M4.10M
Current liabilities8.04B11.9B33.8B31.0B13.0B
Long-term debt950.7M763.5M933.5M500.0M
Total liabilities11.2B13.7B35.5B32.4B34.6B
Shareholders' equity48.1B45.2B-5.90B-253.8M5.08B
Shares outstanding8.13M8.09M8.01M8.01M8.01M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations1.25B-1.20B-4.16B-8.21B-5.40B
Capital spending-3.15B-439.4M-64.5M-195.1M-774.2M
Free cash flow-1.90B-1.64B-4.22B-8.40B-6.17B
Cash from investing-26.4B4.11B-10.9B
Cash from financing28.3B973.6M95.2M
Share buybacks28.9B484.3M46.6M
Change in cash1.84B1.05B888.1M-19.0B15.3B

Open Financials

Cap table

Built by 6ix from Nextbiomedical Co. Ltd.’s releases

Common shares
8,277,286
Fully diluted
8,277,286

Fully diluted

LineShares
Common shares8,277,286

Share count over time

CountShares
Nov 22, 20268,277,286

Open Cap table

Shareholders

HolderSharesValueChangeAs of
Dimensional Emerging Core Equity Market ETF2,268US$55,121NewJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF933US$22,675NewJul 31, 2026
The Emerging Markets Small Cap Series801US$19,365NewJul 31, 2026
Emerging Markets Core Equity 2 Portfolio774US$18,713NewJul 31, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Nextbiomedical Co. Ltd.